Enlightenment Research, LLC Vertex Pharmaceuticals Inc Transaction History

Enlightenment Research, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $256,486 - $302,464	-1,368 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$207.02 - $241.31 $283,203 - $330,112	1,368 New	1,368 $294,000
Q4 2019 Feb 11, 2020	SELL	$166.71 - $223.91 $300,078 - $403,038	-1,800 Closed	0 $0
Q3 2019 Oct 16, 2019	SELL	$166.23 - $187.09 $980,756 - $1.1 Million	-5,900 Reduced 76.62%	1,800 $305,000
Q2 2019 Aug 05, 2019	BUY	$164.61 - $190.37 $1.02 Million - $1.18 Million	6,200 Added 413.33%	7,700 $1.3 Million
Q1 2019 May 03, 2019	BUY	$163.73 - $194.7 $245,594 - $292,050	1,500 New	1,500 $276,000

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Enlightenment Research, LLC, based on Form 13F filings with the SEC.

Stay updated on Enlightenment Research, LLC with notifications on news.